PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a stronger radiation blast tame prostate cancer?
Disease control Recruiting nowThis study is testing whether giving a higher dose of radiation directly to the prostate (called HDR brachytherapy) can better control early-stage prostate cancer without causing too many side effects. About 36 men with low- or favorable intermediate-risk prostate cancer will rec…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 16, 2026 22:04 UTC
-
New radiation drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, LY4257496, that delivers radiation directly to cancer cells with a specific protein (GRPR). It is for adults with advanced solid tumors like breast, prostate, or colorectal cancer that have not responded to other treatments. The goal is to see if the …
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New MRI software could sharpen prostate cancer detection
Diagnosis Recruiting nowThis study tests a new computer tool that creates risk maps from MRI scans to help doctors decide where to biopsy for prostate cancer. About 180 people with known or suspected prostate cancer will have one MRI and one or two biopsies, then be followed for a year. The goal is to s…
Matched conditions: PROSTATE NEOPLASM
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jun 15, 2026 18:57 UTC
-
New hope for men battling hot flashes from prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy (androgen deprivation therapy). About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Jun 05, 2026 12:09 UTC
-
8,000-Patient study aims to sharpen cancer radiation with Real-Time MRI
Knowledge-focused Recruiting nowThis study is a large registry that will follow about 8,000 cancer patients who receive radiation therapy using a special machine called an MR-Linac, which combines an MRI scanner with a radiation beam. The goal is to learn how well this technology works for different cancers, in…
Matched conditions: PROSTATE NEOPLASM
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC
-
Mayo clinic tests sharper MRI for prostate cancer detection
Knowledge-focused Recruiting nowThis study aims to improve MRI scans for prostate cancer by testing new image reconstruction methods. Researchers will compare standard and experimental algorithms to see which produces clearer images. The study involves 1000 adults and does not test any treatment or drug.
Matched conditions: PROSTATE NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC